Global Refractory Follicular Lymphoma Diagnostics Market Projected to Reach USD 464.47 Million by 2029 Refractory Follicular ...

LMNTIC Biotech develops liquid biopsy technology to isolate rare tumor cells in blood LMNTIC Biotech pioneers novel ...

Renovaro will Establish the GEDi CUBE Next Generation Nvidia Blackwell Cluster with Nebul's certified AI Healthcare Cloud solutionsLOS ANGELES, ...

Oral cancer remains a serious global health issue, accounting for a significant portion of head and neck cancer cases ...

We recently published a list of Billionaire Stanley Druckenmiller’s Top 10 Stock Picks. In this article, we are going to take ...

Keywords: Circulating tumor cells (CTCs); Circulating tumor-associated cells; Multiomics; Tumor stroma; Preneoplastic lesions ...

In a study involving 43 MBC patients, the liquid biopsy test reclassified three out of five patients who were initially deemed HER2-negative by tissue biopsy as HER2-positive. This discovery ...

Foresight Diagnostics, Inc. ("Foresight") announced that CEO Jake Chabon will present at the 43rd Annual J.P. Morgan Healthcare Conference on Jan. 15.

A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the ...

Bioengineers at Caltech have developed a new imaging technology that could offer surgeons a fast and cost-effective way to ...

Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating tumor DNA. Luis E. Raez, MD, medical director and chief scientific officer at ...